tPLGA nanoparticles combined with CCL2/CCR2 inhibitor mitigate post-thrombolytic hemorrhagic transformation

Authors:

Abstract
An MMP-9-responsive tPLGA nanoplatform enables spatiotemporally controlled tPA delivery for targeted thrombolysis. Coupling with CCL2/CCR2 inhibition suppresses neuroinflammation, preserves BBB integrity, and prevents hemorrhagic transformation.
Funding Information
  • National Natural Science Foundation of China (U22A20161)
  • National Natural Science Foundation of China (52495011)
  • National Natural Science Foundation of China (52473324)
  • National Natural Science Foundation of China (32401180)
  • Sichuan Provincial Science and Technology Support Program (2024NSFTD0002)
  • Southwest Jiaotong University
  • National Key Research and Development Program of China (2022YFA1206500)

This publication has 45 references indexed in Scilit: